Incremental and Decremental PEEP Titration by Diverse Strategies in Subjects with ARDS: a Prospective Physiological Study

NCT ID: NCT06808438

Last Updated: 2025-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

31 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-01

Study Completion Date

2024-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators conducted a prospective physiological observation study on ARDS population, described their physiological and EIT indexes with various PEEP titration methods, and also compared and analyzed those indexes to determine whether there were differences among various PEEP titration methods.The objective of this study was to explore and uncover the physiological differences in response to optimal PEEP in different ways,and analyzed the correlation of the optimal PEEP in these different ways.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ARDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Esophageal pressure catheter

Esophageal pressure was monitored with an esophageal pressure catheter

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Intubated and mechanical ventilated patients in ICU within 48 hours
* Be over 18 years old
* With moderate-severe ARDS (PaO2 /FIO2 ,200 mm Hg)

Exclusion Criteria

* Severe chronic obstructive pulmonary diseases
* Pulmonary bulla(\>1CM) or pneumothorax or pneumomediastinum or subcutaneous emphysema
* Pregnancy
* BMI≥35kg/m2
* Suspected pulmonary vascular hemorrhage
* Disturbance of consciousness or intracranial hypertension
* Severe cardiac dysfunction (New York Heart Association Class III or IV, acute -Coronary syndrome or persistent ventricular tachyarrhythmia), cardiogenic shock or after major cardiac surgery
* Hemodynamic instability (i.e., mean arterial pressure \[MAP\]\<60 mm Hg despite vasopressor use
* The medical team considering short periods of high pressure to be unsafe
* Contraindications for placement of esophageal pressure catheters (e.g., esophageal varix or fracture of skull base)
* Contraindications for EIT monitoring (including pacemaker, or cutaneous diseases which limiting electrode placement)
* Agonal stage or end-stages of diseases
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West China Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhou Yongfang

Chief respiratory therapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

West China Hospital of Sichuan University, Chengdu

Chengdu, Sichuan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022YFC2504403

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

PEEP Titration

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lung EIT Image Guide Ventilation in ARDS
NCT07309783 NOT_YET_RECRUITING NA